Highly purified. Generating reliable and reproducible results.
Antigenic Blocking Peptide Tudor domain-containing protein 1. The TDRD1 Blocking Peptide is derived from Synthetic. The TDRD1 Blocking Peptide has been validated for the following applications: Antibody Competition.
| Marque | Novus Biologicals |
|---|---|
| Réf. B-LABO | BL-RE-142654 |
| Réf. fabricant | 18001289 |
| Gene ID (Entrez) | 56165 |
| Espèces | Human |
| Pureté | >85%, by HPLC |
| Contenu et stockage | Store at -20 C. Avoid freeze-thaw cycles. |
| Formule | Sodium Bicarbonate buffer, pH 8.00 containing up to 10% DMSO |
| À utiliser avec (application) | This Peptide is Useful as a Blocking Peptide for NBP2-11487. For Further Blocking Peptide Related Protocol, Click Here . |
| Alias de gène | CT41.1 Cancer/testis antigen 41.1, FLJ21082, tudor domain containing 1, tudor domain containing protein 1, tudor domain-containing protein 1 |
| Symbole de gène(s) | TDRD1 |
| Type de produit | TDRD1 |
| Quantité | 0.25 mg |
| État réglementaire | RUO - research use only |
| Consigne | Blocking Peptide for NBP2-11487 |
